Neuroblastoma Program

Meet our team

Our staff of compassionate and experienced pediatric specialists includes hematologist oncologists and radiation oncologists with expertise in treatment neuroblastoma. Our physicians are focused on family-centered care: From your first visit, you’ll work with a team of professionals who are committed to supporting all of your family’s physical and psychosocial needs.

• Suzanne Shusterman, MD, director of the Neuroblastoma Program
  Shusterman is a hematologist oncologist specializing in the treatment of pediatric neuroblastoma. She is an attending physician at Children’s Hospital Boston and an assistant professor of Pediatrics at Harvard Medical School. Her research efforts focus on the development of new treatments for neuroblastoma.
• Lisa R. Diller, MD
  Diller is an experienced hematologist oncologist, the Chief Medical Officer of Dana-Farber/Children’s Hospital Cancer Center and the Clinical Director of Pediatric Oncology at Dana Farber. She specializes in the treatment of solid tumors, including neuroblastoma and Wilms’ tumor, and the late effects of pediatric cancer.
• Rani George, MD, PhD
  George is an attending physician at Children’s. In addition, she is an assistant professor of Pediatrics at Harvard Medical School. Her research focuses in developing new, targeted therapies for the treatment of neuroblastoma.
• Karen J. Marcus, MD
  Marcus joined the Dana Farber/Children’s Hospital Cancer Center in 1989 and specializes in pediatric oncology and radiation oncology. She treats children with a wide variety of cancers including brain tumors, sarcomas, neuroblastoma, leukemias, kidney tumors, and Hodgkin lymphoma. In addition, she is an associate professor at Harvard Medical School and co-chair of Pediatric Oncology Institutional Review Board.
• Robert C. Shamberger, MD
  Shamberger is Children’s Chief of Surgery and has expertise in surgical oncology. He is a professor of Surgery at Harvard Medical School. His research focuses on the treatment of neuroblastoma, Ewing’s sarcoma, Wilms’ tumor and inflammatory bowel disease.
• Christopher Weldon, MD, PhD
  Weldon is a pediatric general surgeon with expertise in pediatric oncology and surgical critical care. His research focuses on chemotherapy resistance in solid tumors. He is also an instructor at Harvard Medical School.